• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

UEMURA Hirotsugu  植村 天受

ORCIDConnect your ORCID iD *help
… Alternative Names

植村 大受  ウエムラ ヒロツグ

Less
Researcher Number 90213397
Other IDs
External Links
Affiliation (Current) 2022: 近畿大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2010 – 2022: 近畿大学, 医学部, 教授
2004 – 2008: 近畿大学, 医学部, 教授
2007: Kinki University, 近畿大学, 教授
2004: Kinki Univ., Dept.of Urology, Professor, 泌尿器科, 教授
2003: Nara Med.University, Dept.Urology, Professor, 医学部, 助教授 … More
2003: 奈良県立医科大学, 泌尿器科, 助教授
2002: Nara Medical Univ, DEPT. OF UROLOGY, LECTURER, 講師
1996 – 2002: Nara Med.Univ., Dept.Urol., Staff, 医学部, 講師
1995 – 1996: 奈良県立医科大学, 医学部, 助手 Less
Review Section/Research Field
Principal Investigator
Urology / Urology / Basic Section 56030:Urology-related
Except Principal Investigator
Urology / Urology / Basic Section 56030:Urology-related / Experimental pathology
Keywords
Principal Investigator
腎細胞癌 / CA9 / MN / ペプチドワクチン / renal cell carcinoma / 免疫療法 / EPOR / 癌ワクチン / VEGFR / 腎細胞がん … More / 癌ワクチン療法 / HIF-1 / PDL-1 / MAbG250 / Immunotherapy / RT-PCR / 抗原ペプチド / VHL / 腎癌 / ペプチドワクチン療法 / HIF-1α / PDL / CA9抗原 / ペプチド / ワクチン療法 / HLA-A24 / オートファジー / 前立腺癌 / マウスモデル / ノックアウトマウス / PTEN / Cre-LoxPシステム / 去勢抵抗性がん / Atg7 / Atg-7 / 抗イディオタイプ抗体 / Renal cell carcinoma / Anti-idiotype antibody / G250 / 血中腎癌細胞 / MN抗原 / 血中癌細胞 / CA IX / G250 antigen / G250 gene / marker / 特異的免疫療法 / specific immunotherapy / CAIX / antigen peptide / cancer vaccine / DNAメチル化 / DNA methylation / CA9 (Carbonic Anhydrase 9) / peptide vaceine / がんワクチン / HLA-A2 / 複合免疫療法 / バイオマーカー … More
Except Principal Investigator
前立腺癌 / MN / CA9 / RT-PCR / 動物モデル / PTEN / Renal cell carcinoma / 腎細胞癌 / 分子標的治療 / ペプチド / バイオマーカー / Cre-LoxPシステム / 泌尿器癌 / PTEN癌抑制遺伝子 / 遺伝子治療 / 遺伝子改変マウスモデル / ノックアウトマウス / マウスモデル / 去勢抵抗性がん / マーカー / ペプチドワクチン / HLA-A3 / EZH2 / 遺伝子改変マウス / p53 / 前臨床試験 / PTENノックアウトマウス / PTEN/p53 DKO / PSAコンディショナル / MN抗原 / mAbG250 / 免疫組織化学 / G250抗原 / MAbG250 / Anti-idiotype antibody / Immunotherapy / 抗体 / antibody / プロモーター / DNAメチル化 / DNA メチル化 / プロモータ / methylation / 血中癌細胞 / renal cell carcinoma / antigen peptide / SEREX法 / Urological tumor / SEREX / Prostate cancer / PTEN tumor suppressor gene / gene therapy / 分子マーカー / 放射線療法 / ペプチド療法 / Prostate Cancer / Molecular Therapy / PTEN Tumor Suppressor Gene / Peptide / ノンコーディングRNA / バイオマーカ / PTENノックアウト / 腫瘍免疫 / トランスクリプトーム解析 / L型アミノ酸トランスポーター / LAT1 / ARV7 / 4F2hc / Liquid Biopsy / cfDNA / CRPC / 前立腺がん / アミノ酸トランスポーター / 去勢抵抗性 / 腫瘍微小免疫環境 / 複合免疫療法 Less
  • Research Projects

    (27 results)
  • Research Products

    (167 results)
  • Co-Researchers

    (33 People)
  •  腎細胞がんに対する癌ワクチンを用いた複合免疫療法の有用性に関する検討Principal Investigator

    • Principal Investigator
      植村 天受
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  Establishment of aminoacid transporter directed prostate cancer therapy based on the liquid biopsy

    • Principal Investigator
      坂本 信一
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Chiba University
  •  前立腺癌における腫瘍微小免疫環境の変化に関する基礎的研究

    • Principal Investigator
      デベラスコ マルコ
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  腎細胞癌に対するマルチペプチド癌ワクチンの開発、複合免疫療法としての有用性の検討Principal Investigator

    • Principal Investigator
      植村 天受
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  Noncoding RNA expression profiling in mouse PTEN-deficient prostate cancer as a potential biomarker

    • Principal Investigator
      DE VELASCO Marco
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.Principal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Development of PSA-conditional PTEN/p53 double knockout mouse prostate cancer model

    • Principal Investigator
      DE VELASCO Marco
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Functional analysis of autophagy in PTEN/Atg7 double knockout mouse prostate cancerPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2014 – 2015
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Development of multi-peptide tumor vaccine for renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Identification of cancer-derived peptides as potential candidates for the development of anti-cancer vaccines for prostate cancer patients

    • Principal Investigator
      MINAMI Takafumi
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Development of tailor made peptide vaccines for renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Pre-clinical applications using PTEN-knockout prostate cancer mouse model

    • Principal Investigator
      DE VELASCO Marco
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Development of tailor-madepeptide vaccines for renal eell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Novel molecular therapeutic strategies in prostate cancer

    • Principal Investigator
      TANAKA Motoyoshi
    • Project Period (FY)
      2007 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Molecular Therapy Targeting PTEN-Akt Signaling Pathway in Prostate Cancer.

    • Principal Investigator
      TANAKA Motoyoshi
    • Project Period (FY)
      2005 – 2006
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Kinki University
      Nara Medical University
  •  Development new generation peptides derived from CA9 as tailar-made vaccines for renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2004 – 2006
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Application for PTEN Gene Therapy in Prostate Cancer

    • Principal Investigator
      TANAKA Motoyoshi
    • Project Period (FY)
      2003 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Nara Medical University School of Medicine
  •  MN/CA9 expression and VHL regulation in renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu, 趙 順規
    • Project Period (FY)
      2002 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Nara Medical University
  •  Active specific immunotherapy with MN\CA IX antigen peptide vaccines for renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2001 – 2002
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Nara Medical University
  •  Search for new target antigens of cancer by the SEREX method using cancer patient's serum containing antibodies

    • Principal Investigator
      YOSHIKAWA Kazuhiro
    • Project Period (FY)
      2001 – 2002
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      AICHI MEDICAL UNIVERSITY
  •  Clinical Significance for detection of circulating renal cancer cells in the blood by RT-PCR

    • Principal Investigator
      HIAO Yoshihiko
    • Project Period (FY)
      2000 – 2002
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Nara Medical University
  •  Elucidation of activation mechanism of MN/CA9 in human renal cell carcinomas

    • Principal Investigator
      CHO Masaki
    • Project Period (FY)
      1999 – 2000
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Experimental pathology
    • Research Institution
      NARA MEDICAL UNIVERSITY
  •  Specific immunotherapy targeting MN/CA9 tumor-associated antigen for renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      1999 – 2000
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Nara Medical University
  •  Establishment of diagnosis and therapy in renal cell carcinomas by MN/CAIX antibody

    • Principal Investigator
      HIRAO Yoshihiko, 仲川 嘉紀
    • Project Period (FY)
      1998 – 1999
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      NARA MEDICAL UNIVERSITY
  •  Molecular detection of circulating renal cell carcinoma cells by RT-PCRPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      1997 – 1998
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      Nara Medical University
  •  A tumor-associated antigen MN/G250 in urologic malignancies ; potetial therapeutic target

    • Principal Investigator
      HIRAO Yoshihiko, 百瀬 均
    • Project Period (FY)
      1996 – 1997
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      NARA MEDICAL UNIVERSITY
  •  Tools for active specific immunotherapy with anti-idiotype antibodies in human renal cell carcinomaPrincipal Investigator

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      1995 – 1996
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Urology
    • Research Institution
      NARA MEDICAL UNIVERSITY

All 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Other

All Journal Article Presentation Book Patent

  • [Book] Year Book of RCC 2008. RCCに対する癌ワクチン療法のトピックス2008

    • Author(s)
      植村天受
    • Publisher
      メディカルレビュー社
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Book] Cancer Treatment Navigator 腎癌の分子標的治療2008

    • Author(s)
      植村天受
    • Publisher
      メディカルレビュー社
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer2020

    • Author(s)
      De Velasco Marco A, Kura Y, Sakai K, Hatanaka Y, Davies BR, Campbell H, Klein S, Kim Y, MacLeod AR, Sugimoto K, Yoshikawa K, Nishio K, Uemura H.
    • Journal Title

      Human Cell

      Volume: 7 Pages: 730-736

    • DOI

      10.1007/s13577-020-00337-7

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165, KAKENHI-PROJECT-18K09178
  • [Journal Article] HOXA10 expression profiling in prostate cancer2019

    • Author(s)
      Hatanaka Yuji、de Velasco Marco A.、Oki Takashi、Shimizu Nobutaka、Nozawa Masahiro、Yoshimura Kazuhiro、Yoshikawa Kazuhiro、Nishio Kazuto、Uemura Hirotsugu
    • Journal Title

      The Prostate

      Volume: 79 Pages: 554-563

    • DOI

      10.1002/pros.23761

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K11165, KAKENHI-PLANNED-17H06404
  • [Journal Article] Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy2019

    • Author(s)
      De Velasco Marco A.、Kura Yurie、Sakai Kazuko、Hatanaka Yuji、Davies Barry R.、Campbell Hayley、Klein Stephanie、Kim Youngsoo、MacLeod A. Robert、Sugimoto Koichi、Yoshikawa Kazuhiro、Nishio Kazuto、Uemura Hirotsugu
    • Journal Title

      JCI Insight

      Volume: 4

    • DOI

      10.1172/jci.insight.122688

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Journal Article] Generation of PTEN-knockout (-/-) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling2018

    • Author(s)
      Takao Akiko、Yoshikawa Kazuhiro、Karnan Sivasundaram、Ota Akinobu、Uemura Hirotsugu、De Velasco Marco、Kura Yurie、Suzuki Susumu、Ueda Ryuzo、Nishino Tokiko、Hosokawa Yoshitaka
    • Journal Title

      Oncology Reports

      Volume: 40 Pages: 2455-2466

    • DOI

      10.3892/or.2018.6683

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K11165, KAKENHI-PROJECT-18K08342
  • [Journal Article] Hypoxia-inducing factor (HIF)-1a;-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017

    • Author(s)
      1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      International Immunopharmacology

      Volume: 44 Pages: 197-202

    • DOI

      10.1016/j.intimp.2017.01.014

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
  • [Journal Article] Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer.2016

    • Author(s)
      De Velasco MA, Kura Y, Yoshikawa K, Nishio K, Davies BR, Uemura H.
    • Journal Title

      Oncotarget.

      Volume: 7 Pages: 15959-15976

    • DOI

      10.18632/oncotarget.7557

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-26670707, KAKENHI-PROJECT-26462433
  • [Journal Article] Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer.2015

    • Author(s)
      Yamamoto Y, De Velasco MA, Kura Y, Nozawa M, Hatanaka Y, Oki T, Ozeki T, Shimizu N, Minami T, Yoshimura K, Yoshikawa K, Nishio K, Uemura H.
    • Journal Title

      J Transl Med.

      Volume: 13 Pages: 150-162

    • DOI

      10.1186/s12967-015-0509-x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670707
  • [Journal Article] New polycomb group protein enhancer of zeste homolog(EZH)2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 26 Pages: 133-138

    • DOI

      10.1016/j.intimp.2015.03.023

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] Identification of Programmed Death Ligand 1-derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24+ Patients With Renal Cell Carcinoma.2015

    • Author(s)
      Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
    • Journal Title

      J Immunother.

      Volume: 38 (7) Pages: 285-289

    • DOI

      10.1097/cji.0000000000000090

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.2015

    • Author(s)
      Koike H1, Nozawa M, De Velasco MA, Kura Y, Ando N, Fukushima E, Yamamoto Y, Hatanaka Y, Yoshikawa K, Nishio K, Uemura H.
    • Journal Title

      Asian Pac J Cancer Prev.

      Volume: 16 Pages: 1827-1831

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer2014

    • Author(s)
      M.A. De Velasco, M. Tanaka, Y. Yamamoto, Y. Hatanaka, H. Koike, K. Nishio, K. Yoshikawa and H. Uemura
    • Journal Title

      Carcinogenesis

      Volume: 35 Pages: 2142-2153

    • DOI

      10.1093/carcin/bgu143

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system.2014

    • Author(s)
      Harashima N, Minami T, Uemura H, Harada M
    • Journal Title

      Mol Cancer.

      Volume: 13 Pages: 217-217

    • DOI

      10.1186/1476-4598-13-217

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25293336, KAKENHI-PROJECT-25430150
  • [Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.2013

    • Author(s)
      Yoshimura K, Minami T, Nozawa M, Uemura H.
    • Journal Title

      Br J Cancer.

      Volume: 108 Pages: 1260-1266

    • DOI

      10.1038/bjc.2013.90

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
  • [Journal Article] Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma2013

    • Author(s)
      Yoshimura K, Minami T, Nozawa M, Uemura H
    • Journal Title

      Br J Cancer

      Volume: 108(6) Pages: 1260-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma2013

    • Author(s)
      Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S
    • Journal Title

      Japan Immunotherapy SNPs-Study Group for Kidney Cancer

      Volume: Eur Urol Pages: 745-52

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell Carcinoma.2013

    • Author(s)
      Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S; Japan Immunotherapy SNPs-Study Group for Kidney Cancer.
    • Journal Title

      European Urology

      Volume: 63 Pages: 745-752

    • DOI

      10.1016/j.eururo.2012.09.052

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-24592391, KAKENHI-PROJECT-24659718
  • [Journal Article] Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy.2013

    • Author(s)
      Yoshimura K, Uemura H. Yoshimura K, Uemura H.
    • Journal Title

      Int J Urol.

      Volume: - Pages: 1-10

    • DOI

      10.1111/iju.12147

    • NAID

      10031190532

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305, KAKENHI-PROJECT-25293336
  • [Journal Article] Preclinical remodeling of human prostate cancer through the PTEN/Akt pathway2012

    • Author(s)
      De Velasco MA and Uemura H
    • Journal Title

      Adv Urol

      Volume: 2012 Pages: 419348-419348

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Journal Article] Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway.2012

    • Author(s)
      De Velasco MA, Uemura H.
    • Journal Title

      Adv Urol.

      Volume: -

    • DOI

      10.1155/2012/419348

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Journal Article] A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system2011

    • Author(s)
      Zennami K, Yoshikawa K, Kondo E,, De Velasco MA, Tanaka M, Uemura H, et al.
    • Journal Title

      Oncol Rep.

      Volume: 26 Pages: 327-333

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Journal Article] A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system2011

    • Author(s)
      Zennami K, Yoshikawa K, Kondo E, Nakamura K, Upsilonamada Y, De Velasco MA, Tanaka M, Uemura H, Shimazui T, Akaza H, Saga S, Ueda R, Honda N
    • Journal Title

      Oncol Rep.

      Volume: 26 Pages: 327-333

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Basic research in kidney cancer2011

    • Author(s)
      Oosterwijk E, Rathmell WK, Junker K, Brannon AR, Pouliot F, Finley DS, Mulders PF, Kirkali Z, Uemura H
    • Journal Title

      Belldegrun A

      Volume: Eur Urol Pages: 622-33

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-12011

    • Author(s)
      Tsukamoto T, Shinohara N, Tsuchiya N, Hamamoto Y, Maruoka M, Fujimoto H, Niwakawa M, Uemura H, Usami M, Terai A, Kanayama HO, Sumiyoshi Y, Eto M, Akaza H
    • Journal Title

      Jpn J Clin Oncol

      Volume: 41(1) Pages: 17-24

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Kidney Cancer Working Group report.2011

    • Author(s)
      Naito S., Uemura H., et al.
    • Journal Title

      Jpn J Clin Oncol.

      Volume: Suppl1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivo2011

    • Author(s)
      Kudo K, Arao T, De Velasco MA, Hirotsugu Uemura et al
    • Journal Title

      Clin Cancer Res

      Volume: 15;17(6) Pages: 1373-81

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy.2010

    • Author(s)
      Kishida T., Uemura H.
    • Journal Title

      Int J Urol.

      Volume: 17 Pages: 198-205

    • NAID

      10027257218

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Assessment of immunological biomarkers in patients with advanced capcer treated by personalized peptide vaccination.2010

    • Author(s)
      Noguchi M., Uemura H., et al.
    • Journal Title

      Cancer Biol Ther.

      Volume: 10 Pages: 1266-1279

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Kidney Cancer Working Group report2010

    • Author(s)
      Naito S, Tomita Y, Rha SY, Uemura H, Oya M, Song HZ, Zhong LH, Wahid MI
    • Journal Title

      Jpn J Clin Oncol

      Volume: 40 Suppl 1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination2010

    • Author(s)
      Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K
    • Journal Title

      Cancer Biol Ther

      Volume: 10(12) Pages: 1266-79

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Journal Article] GFP image analysis in the mouse orthotopic bladder cancer model2008

    • Author(s)
      DeVelasco, M., Tanaka, M., Anai, S., Tomioka, A., Nishio, K., Uemura, H.
    • Journal Title

      Oncology Report 20

      Pages: 537-542

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591876
  • [Journal Article] Phase I/II study of individualized peptide vaccines for HLA-A2/24 positive patients with hormone-refractory prostate cancer2008

    • Author(s)
      Uemura H., Minami T., Tanaka M, 他4名
    • Journal Title

      J. Clin. Oncol. 26

    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation2008

    • Author(s)
      Tomioka, A., Tanaka, M., DeVelasco, M. Anai, S., Takada, S., Kushibiki, T., Tabata, Y., Rosser, C. J., Uemura, H., Hirao, H.
    • Journal Title

      Molecular Cancer Therapeutics 7

      Pages: 1864-1870

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591876
  • [Journal Article] Tumor vaccines in renal cell carcinoma2008

    • Author(s)
      Uemura H., De Velasco M.
    • Journal Title

      World J. Urol. 26

      Pages: 147-154

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] 腎細胞癌に対する免疫療法の新しい可能性2008

    • Author(s)
      植村天受
    • Journal Title

      Urology View 6

      Pages: 73-77

    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] 泌尿器腫瘍と癌抑制因子2008

    • Author(s)
      植村天受
    • Journal Title

      泌尿紀要 54

      Pages: 49-52

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] 野揮昌弘.腎細胞癌に対する免疫療法の新しい可能性2008

    • Author(s)
      植村天受, 野澤昌弘
    • Journal Title

      Urology View 6

      Pages: 73-77

    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] GFP image analysis in the mouse orthotopic bladder cancer model2008

    • Author(s)
      De Velasco M., Tanaka M., Uemura H, 他3名
    • Journal Title

      Oncol Rep 20

      Pages: 537-542

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation2008

    • Author(s)
      Tomioka A., Tanaka M., De Velasco M. Uemura H, 他7名
    • Journal Title

      Mol Cancer Ther 7

      Pages: 1864-1870

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Tumor vaccines in renal cell carcinoma2008

    • Author(s)
      H. Uemura
    • Journal Title

      World J. Urol. 26

      Pages: 147-154

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Identification of SART3-derived peptides having the potential to induce cancer- reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.2007

    • Author(s)
      Minami T., Matsueda S., Uemura H., et al.
    • Journal Title

      Cancer Imuunol Immunother (In press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 陣癌に対するCA9ペプチドワクチン療法2007

    • Author(s)
      植村天受
    • Journal Title

      泌尿器外科 20・1

      Pages: 17-23

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] CA9 peptide vaccination therapy for renal cell carcinoma.2007

    • Author(s)
      Uemura H.
    • Journal Title

      Jap J. Urol. Surgery 20

      Pages: 17-23

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] STAT3 polymorphism predicts mterferon-alfa response in patients with metastatic renal cell carcinoma2007

    • Author(s)
      Ito N.,Uemura H, 他18名
    • Journal Title

      J. Clin. Oncol. 25

      Pages: 2785-2791

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Idenitification of SART3-derived peptides having the potential to induce cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Minami T., Uemura H., Harada M, 他5名
    • Journal Title

      Cancer Immunol.Immunother 56

      Pages: 689-698

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] 腎癌に対するCA9ペプチドワクチン療法2007

    • Author(s)
      植村天受
    • Journal Title

      泌尿器外科 20

      Pages: 17-23

    • Data Source
      KAKENHI-PROJECT-19390419
  • [Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Minami T., Matsueda S., Uemura H., et al.
    • Journal Title

      Cancer Imuunol Immunother (In press)

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 腎癌に対するCA9ペプチドワクチン療法2007

    • Author(s)
      植村天受
    • Journal Title

      泌尿器外科 20・1

      Pages: 17-23

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Minami T, Matsueda S, Uemura H., et al.
    • Journal Title

      Cancer Imuunol Immunother (In press)

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 腎細胞癌に対するCA9ペプチドワクチン療法2006

    • Author(s)
      上島成也, 植村天受
    • Journal Title

      Biotherapy 20

      Pages: 484-489

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] ワクチン療法の理論と実際2006

    • Author(s)
      植村天受
    • Journal Title

      Urology View 4・1

      Pages: 83-89

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] A phase I trail of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma2006

    • Author(s)
      Uemura H., Fujimoto K., Tanaka M., et al.
    • Journal Title

      Clin Cancer Res 12・6

      Pages: 1768-1775

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients With cytokine-refractory metastatic renal cell carcinoma.2006

    • Author(s)
      Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K
    • Journal Title

      Clinical Cancer Research 12

      Pages: 1768-1775

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-17591697
  • [Journal Article] A phase l trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.2006

    • Author(s)
      Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K
    • Journal Title

      Clinical Cancer Research 12

      Pages: 1768-1775

    • Data Source
      KAKENHI-PROJECT-17591697
  • [Journal Article] A phase I trail of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renalcell carcinoma2006

    • Author(s)
      Uemura H, Fujimoto K, Tanaka M., et al.
    • Journal Title

      Clin Cancer Res 12・6

      Pages: 1768-1775

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 「研究成果報告書概要(欧文)」より2006

    • Author(s)
      Uejima S., Uemura H.
    • Journal Title

      Biotherapy 20

      Pages: 484-489

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma2006

    • Author(s)
      Uemura H., Fujimoto K., et al.
    • Journal Title

      Clinical Cancer Research 12・6(in press)

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] Fujimoto K., Tanaka M., et al., A phase I trail of vaccination of CA9-derived peptides for HLA-A24- positive patients with cytokine-refractory metastatic renal cell carcinoma.2006

    • Author(s)
      Uemura H.
    • Journal Title

      Clin Cancer Res 12

      Pages: 1768-1775

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 泌尿器科癌に対するペプチドワクチン療法2005

    • Author(s)
      植村天受
    • Journal Title

      Urology View 3・3

      Pages: 102-107

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] Vaccination therapy for renal cell carcinoma.2005

    • Author(s)
      Uemura H.
    • Journal Title

      Annual Review

      Pages: 221-225

    • NAID

      40017065250

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.2005

    • Author(s)
      Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K.
    • Journal Title

      Clinical Cancer Research 12

      Pages: 1768-1775

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-17591697
  • [Journal Article] Peptide vaccination therapy for urologic cancers.2005

    • Author(s)
      Uemura H.
    • Journal Title

      Urology View 13

      Pages: 102-107

    • NAID

      40022581955

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 泌尿器科癌に対するペプチドワクチン療法2005

    • Author(s)
      植村天受
    • Journal Title

      Urology View 13・3

      Pages: 102-107

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 腎細胞癌のワクチン療法2005

    • Author(s)
      植村天受
    • Journal Title

      Annual Review 2005 腎臓

      Pages: 221-225

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 腎細胞癌のワクチン療法2005

    • Author(s)
      植村天受
    • Journal Title

      Annual Review

      Pages: 221-225

    • Description
      「研究成果報告書概要(和文)」より
    • Data Source
      KAKENHI-PROJECT-16390468
  • [Journal Article] 腎細胞癌治療の現状と課題:腎細胞癌におけるITC(isolated tumor cell)の意義2004

    • Author(s)
      植村天受
    • Journal Title

      泌尿器外科 17

      Pages: 661-665

    • Data Source
      KAKENHI-PROJECT-16390468
  • [Patent] HIF-1α由来ペプチド、及びそれを含む金細胞がんワクチン2019

    • Inventor(s)
      植村天受
    • Industrial Property Rights Holder
      植村天受
    • Industrial Property Number
      2016-209180
    • Filing Date
      2019
    • Acquisition Date
      2021
    • Data Source
      KAKENHI-PROJECT-19H03794
  • [Patent] HLA-A24分子に結合でき、かつ細胞性免疫に認識されるHIF-1α由来ペプチド、及びそれを含む腎細胞癌ワクチン2016

    • Inventor(s)
      植村天受、南高文
    • Industrial Property Rights Holder
      植村天受、南高文
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2016-209180
    • Filing Date
      2016-10-26
    • Data Source
      KAKENHI-PROJECT-16H05466
  • [Patent] 細胞性免疫に認識されるペプチド、及びそれを利用した医薬薬剤2014

    • Inventor(s)
      植村天受
    • Industrial Property Rights Holder
      植村天受
    • Industrial Property Rights Type
      特許
    • Filing Date
      2014-09-17
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Patent] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なEZH2由来ペプチド2014

    • Inventor(s)
      植村 天受
    • Industrial Property Rights Holder
      植村 天受
    • Industrial Property Rights Type
      特許
    • Filing Date
      2014-09-26
    • Data Source
      KAKENHI-PROJECT-24592416
  • [Patent] 腎細胞がんの予防又は治療に好適なペプチド、核酸分子、及びベクター、並びにそられの利用2014

    • Inventor(s)
      植村天受
    • Industrial Property Rights Holder
      植村天受
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2014-007671
    • Filing Date
      2014-01-20
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Presentation] Targeting extracellular adenosine in mouse Pten-deficient prostate cancer2021

    • Author(s)
      Marco A. De Velasco, Yurie Kura,Naomi Ando, Kazuko Sakai, Alwin Schuller, Kazuto Nishio, and Hirotsugu Uemura
    • Organizer
      第18回日本臨床腫瘍学会学術集会
    • Data Source
      KAKENHI-PROJECT-20K09570
  • [Presentation] アンドロゲン受容体標的治療による前立腺癌の腫瘍微小環境の変化2020

    • Author(s)
      デベラスコ・マルコ、倉 由吏恵、坂井 和子、清水 信貴、森 康則、野澤 昌弘、吉村 一宏、吉川 和宏、西尾 和人、植村 天受
    • Organizer
      第108回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-20K09570
  • [Presentation] Androgen deprivation following JAK1/2 and PD-L1 inhibition improves antitumor efficacy in mouse models of Pten-deficient prostate cancer2020

    • Author(s)
      Marco A. De Velasco, Yurie Kura, Naomi Ando, Noriko Sato, Kazuko Sakai, Kazuhiro Yoshikawa, Kazuto Nishio, and Hirotsugu Uemura
    • Organizer
      Annual Meeting of the American Association for Cancer Research 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K09570
  • [Presentation] Cross-species analysis and immunophenotyping using of a focused panel of immune-responsive genes2020

    • Author(s)
      Marco A. De Velasco, Yurie Kura,Kazuko Sakai, Hideki Nakagaki,Kazuto Nishio, and Hirotsugu Uemura
    • Organizer
      Annual Meeting of the American Association for Cancer Research 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K09570
  • [Presentation] Targeting A2aR in mouse Pten-deficient prostate cancer2020

    • Author(s)
      Marco A.De Velasco,Yurie Kura, Noriko Sako, NaomiAndo, Kazuko Sakai, Masahiro Nozawa, Kazuhiro Yoshimura,Kazuhiro Yoshikawa,Alwin Schuller,Kazuto Nishio and Hirotsugu Uemura
    • Organizer
      Annual Meeting of the American Association for Cancer Research 2020
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K09570
  • [Presentation] Profiling the tumor immune milieu to assess and predict immune responses2019

    • Author(s)
      デベラスコ・マルコ、倉由吏恵、森康範、大関孝之、坂井和子、野澤昌弘、吉村一弘、吉川和宏、西尾和人、植村天受
    • Organizer
      第78日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] リアルタイムPCRを用いた腫瘍免疫プロファイルと免疫反応性の評価んについて2019

    • Author(s)
      野澤 昌弘、デベラスコ・マルコ、倉 由吏恵、坂井 和子、吉川 和宏、西尾 和人、植村 天受
    • Organizer
      第78回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Pim キナーゼ阻害薬は去勢抵抗性前立腺癌マウスモデルにおいて腫瘍増殖を抑制し生存期間を延長する2019

    • Author(s)
      倉 由吏恵、清水 信貴、森 康範、南 高文、野澤 昌弘、吉村一宏、西尾和人、デベラスコ・マルコ、植村 天受
    • Organizer
      第23回 日本がん分子標的治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] A real-time PCR-based approach to quantitatively assess tumor immune profiles and immune responses2019

    • Author(s)
      デベラスコ・マルコ、倉 由吏恵、佐古紀子、安藤直美、坂井和子、森 康範、Barry R.Davies、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      AACR
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 前立腺癌における遺伝子改変マウスモデル新たな発見と発展のツールとして2019

    • Author(s)
      倉 由吏恵、デベラスコ・マルコ、植村天受
    • Organizer
      第107日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Dietary isoflavone decreases prostate cancer progression and improves survival in conditional Pten/Trp53-deficient mice.2019

    • Author(s)
      asunori Mori, Marco A. De Velasco, Yurie Kura, Eri Banno, Naomi Anod, Noriko Sako, Masahiro Nozawa, Kazuhiro Yoshimura, Kazuko Sakai, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
    • Organizer
      AACR2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Apalutamide reworks the immune composition of prostate tumors.2019

    • Author(s)
      Marco A. De Velasco, Yurie Kura, Naomi Anod, Noriko Sako, Masahiro Nozawa, Kazuhiro Yoshimura, Kazuko Sakai, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
    • Organizer
      AACR2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] A real-time PCR-based approach to quantitatively assess tumor immune profiles and immune responses.2019

    • Author(s)
      Marco A. De Velasco, Yurie Kura, Naomi Anod, Noriko Sako, Kazuhiro Yoshimura, Kazuko Sakai, Yasunori Mori, Barry R. Davies, Masahiro Nozawa, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
    • Organizer
      AACR2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Apalutamide reworks the immune composition of prostate tumors2019

    • Author(s)
      デベラスコ・マルコ、倉 由吏恵、安藤直美、佐古紀子、野澤昌弘、吉村一宏、坂井和子、吉川和宏、西尾和人、植村天受
    • Organizer
      AACR
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 前立腺癌における遺伝子改変マウスモデルについて2019

    • Author(s)
      植村天受、倉由吏恵、清水信貴、森康範、南高文、野澤昌弘、西尾和人、デベラスコ・マルコ
    • Organizer
      第107日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] アンドロゲン受溶体標的治療は前立腺癌の腫瘍微小免疫環境えお変化させる2019

    • Author(s)
      植村 天受、デベラスコ・マルコ
    • Organizer
      第78回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 前立腺癌における分子標的薬と次世代アンチセンスオリゴの併用効果について2019

    • Author(s)
      デベラスコ・マルコ、倉由吏恵、坂井和子、藤田至彦、西尾和人、植村天受
    • Organizer
      第23回日本がん分子標的治療学会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Pimキナ-ゼ阻害薬は去勢抵抗性マウス前立腺癌モデルにおいて腫瘍増殖を抑制し生存期間を延長する2018

    • Author(s)
      倉 由吏恵(近大)、デベラスコ・マルコ(近大、近大ゲノム)、森 康範、清水 信貴、大關 孝之(近大)、坂井 和子(近大ゲノム)、野澤 昌弘、吉村 一宏(近大)、吉川 和宏(愛知医大)、西尾 和人(近大ゲノム)、植村 天受(近大)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 免疫療法開発における遺伝子改変マウス前立腺癌モデルの有用性について2018

    • Author(s)
      デベラスコ・マルコ(近大、近大ゲノム)、倉 由吏恵、森 康範、清水 信貴、大關 孝之(近大)、坂井 和子(近大ゲノム)、野澤 昌弘、吉村 一宏(近大)、吉川 和宏(愛知医大)、西尾 和人(近大ゲノム)、植村 天受(近大)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 前立腺癌患者の予後不良に関わる遺伝子絆の同定2018

    • Author(s)
      橋本 士(近大)、デベラスコ・マルコ(近大、近大ゲノム)、倉 由吏恵(近大)、坂井 和子(近大ゲノム)、清水 信貴(近大)、森 康範、野澤 昌弘、吉村 一宏、(近大)、吉川 和宏(愛知医大)、西尾 和人(近大ゲノム)、植村 天受(近大)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 遺伝子改変Pten ノックアウトマウス前立腺癌モデルにおけるApalutamideの有効性についての検討2018

    • Author(s)
      森 康範(近大)、デベラスコ・マルコ(近大、近大ゲノム)、倉 由吏恵(近大)、大關 孝之、清水 信貴、野澤 昌弘、吉村 一宏、(近大)、坂井 和子(近大ゲノム)、吉川 和宏(愛知医大)、西尾 和人(近大ゲノム)、植村 天受(近大)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] ptenノックアウトマウス前立腺癌モデルを用いたアビラテロンによる抗腫瘍免疫効果に関する検討2018

    • Author(s)
      清水 信貴(近大)、デベラスコ・マルコ(近大、近大ゲノム)、倉 由吏恵、大關 孝之、森 康範、野澤 昌弘、吉村 一宏、(近大)、坂井 和子(近大ゲノム)、吉川 和宏(愛知医大)、西尾 和人(近大ゲノム)、植村 天受(近大)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 前立腺癌における遺伝子改変マウスモデル:ヒトからマウスへ-マウスからヒトへ2018

    • Author(s)
      植村 天受(近大)、デベラスコ・マルコ(近大、近大ゲノム)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Ptenノックアウトマウス前立腺癌モデルにおけるマルチキナ-ゼ阻害薬TAS/115の有効性についての検討2018

    • Author(s)
      野澤 昌弘(近大)、デベラスコ・マルコ(近大、近大ゲノム)、倉 由吏恵、清水 信貴、森 康範、吉村 一宏(近大)、坂井 和子(近大ゲノム)、吉川 和宏(愛知医大)、西尾 和人(近大ゲノム)、植村 天受(近大)
    • Organizer
      第77回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Therapeutic potential of combination therapy using a next-generation antisense oligonucleotide targeting the androgen receptor and AKT inhibition with AZD5363 in genetically engineered mouse models of prostate cancer2017

    • Author(s)
      デベラスコ マルコ、倉由吏恵、安藤直美、杉本公一、坂井和子、Barry R. Davies、Youngsoo Kim、A. Robert Macleod、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      AACR
    • Place of Presentation
      ワシントンDC, USA
    • Year and Date
      2017-04-02
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] ヒト前立腺癌におけるSTAT3について2017

    • Author(s)
      森 康範、デベラスコ マルコ、畑中祐二、倉 由吏恵、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] 遺伝子改変マウス前立腺癌モデルを用いた新規化合物の包括的前臨床評価について2017

    • Author(s)
      植村天受、倉 由吏恵、杉本公一、森 康範、野澤昌弘、吉村一宏、吉川和宏、西尾和人、デベラスコ マルコ
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] AKTおよびPimキナーゼをターゲットにした治療戦略はPTEN欠出前立腺癌前臨床動物モデルにおいて治療効果改善を示す2017

    • Author(s)
      倉 由吏恵、デベラスコ マルコ、杉本公一、坂井和子、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] PTENノックアウト前立腺癌マウスモデルにおける腫瘍免疫の包括的分析2017

    • Author(s)
      デベラスコ マルコ、倉 由吏恵、坂井和子、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] Co-targeting of AKT and Pim kinases in mouse PTEN-deficient prostate cance2017

    • Author(s)
      倉由吏恵、デベラスコ マルコ、安藤直美、佐古紀子、杉本公一、坂井和子、Barry R. Davies、Dennis Huszay、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      AACR
    • Place of Presentation
      ワシントンDC, USA
    • Year and Date
      2017-04-02
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] 遺伝子改変前立腺癌マウスモデルにおけるPD-L1免疫チェックポイント阻害薬について2017

    • Author(s)
      清水信貴、デベラスコ マルコ、倉 由吏恵、坂井和子、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11165
  • [Presentation] PD-L1 blockade in preclinical models of PTEN-deficient prostate cancer2017

    • Author(s)
      デベラスコ マルコ、倉由吏恵、安藤直美、佐古紀子、Barry R. Devies、杉本公一、野澤昌弘、吉村一宏、吉川和宏、西尾和人、植村天受
    • Organizer
      AACR
    • Place of Presentation
      ワシントンDC, USA
    • Year and Date
      2017-04-02
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] PTEN/p53ダブルノックアウト前立腺癌マウスモデルにおけるクロ2016

    • Author(s)
      杉本公一、デベラスコ マルコ、倉由吏恵、森康範、畑中祐二、沖貴士、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜、神奈川県横浜市
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] PTENノックアウト前立腺癌マウスモデルにおけるJAK1/2阻害によ2016

    • Author(s)
      植村天受、倉由吏恵、森康範、畑中祐二、沖貴士、杉本公一、吉村一宏、野澤昌弘、吉川和宏、西尾和人、デベラスコ マルコ
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜、神奈川県横浜市
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] 遺伝子改変と前立腺癌マウスモデルにおける高脂肪食摂取による腫瘍増殖2016

    • Author(s)
      森康範、デベラスコ マルコ、倉由吏恵、畑中祐二、沖貴士、杉本公一、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜、神奈川県横浜市
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] PTENノックアウトマウス前立腺癌におけて選択的スプライシング2016

    • Author(s)
      デベラスコ マルコ、倉由吏恵、坂井和子、藤田至彦、冨樫庸介、寺嶋雅人、吉川和宏、西尾和人、植村天受
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜、神奈川県横浜市
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] PTENノックアウトマウス前立腺癌におけるノンコーディングRNAの2016

    • Author(s)
      倉由吏恵、デベラスコ マルコ、坂井和子、藤田至彦、冨樫庸介、寺嶋雅人、吉川和宏、西尾和人、植村天受
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜、神奈川県横浜市
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] Chloroquine demonstrates limited effectiveness in an autochthonous preclinical model of prostate cancer2015

    • Author(s)
      Kura Y., De Velasco MA., Uemura H. et al.
    • Organizer
      AACR
    • Place of Presentation
      フィラデルフィア, アメリカ
    • Year and Date
      2015-04-20
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] Effects of long-term chloroquine chemotherapy in a preclinical model of PTEN-deficier2015

    • Author(s)
      Yoshikawa K., De Velasco M., Uemura H. et al
    • Organizer
      AACR
    • Place of Presentation
      フィラデルフィア, アメリカ
    • Year and Date
      2015-04-20
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26670707
  • [Presentation] Effects of long-term chloroquine chemotherapy in a preclinical model of PTEN-deficier2015

    • Author(s)
      Yoshikawa K., De Velasco MA., Uemura H. et al
    • Organizer
      AACR
    • Place of Presentation
      フィラデルフィア, アメリカ
    • Year and Date
      2015-04-20
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] マウス前立腺癌モデルを用いたAKT阻害薬 AZD 5356の抗腫瘍効果2015

    • Author(s)
      Uemura H., Kura Y., Shimizu N. et al.
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋コングレスセンター
    • Year and Date
      2015-10-09
    • Data Source
      KAKENHI-PROJECT-26670707
  • [Presentation] Chloroquine demonstrates limited effectiveness in an autochthonous preclinical model of prostate cancer2015

    • Author(s)
      Kura Y., De Velasco M., Uemura H. et al.
    • Organizer
      AACR
    • Place of Presentation
      フィラデルフィア, アメリカ
    • Year and Date
      2015-04-20
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26670707
  • [Presentation] Preclinical effects of dual AKT/MAPK inhibition in PTEN-deficient prostate cancer2015

    • Author(s)
      De Velasco MA., Yamamot Y., Uemura H, et al.
    • Organizer
      AACR
    • Place of Presentation
      フィラデルフィア, アメリカ
    • Year and Date
      2015-04-20
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] マウス前立腺癌モデルを用いたAKT阻害薬 AZD 5356の抗腫瘍効果2015

    • Author(s)
      Uemura H., Kura Y., De Velasco MA. et al.,
    • Organizer
      第74回 日本癌学会学術総会
    • Place of Presentation
      名古屋コングレスセンター
    • Year and Date
      2015-10-09
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] 去勢抵抗性前立腺癌に対する免疫療法2015

    • Author(s)
      吉村一宏、植村天受 ほか
    • Organizer
      第65回 日本泌尿器科学会中部総会
    • Place of Presentation
      長良川国際会議場、岐阜都ホテル
    • Year and Date
      2015-10-23
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Presentation] Leptin contributes to prostate cancer progression.2013

    • Author(s)
      Marco A De Velasco, Yutaka Yamamoto, Yuji Hatanaka, Yurie Kura, Naomi Ando, Emiko Fukushima, Masahiro Noazawa, Nobutaka Shimizu, Kazuhiro Yoshimura, Kazuhiro Yoshikawa, Kazuto Noshio, Hirotsugu Uemura.
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington DC
    • Year and Date
      2013-04-09
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Therapeutic potential of JAK/STAT signal inhibition in prostate cancer by the JAK inhibitor AZD14802013

    • Author(s)
      Marco A. De Velasco, Hirotsugu Uemura, et al
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington DC
    • Year and Date
      2013-04-07
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Clinical role of MHC-class I peptide vaccines for metastatic renal cell carcinoma2013

    • Author(s)
      T Minami, T Minami, N Shimizu, Y Yamamoto, M De Velasco, T Hayashi, M Nozawa, K Yoshimura, T Ishii, H Uemura
    • Organizer
      28th Annual EAU Congress
    • Place of Presentation
      Milan
    • Year and Date
      2013-03-18
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] Interleukin-6 (IL-6) as a therapeutic target in prostate cancer.2013

    • Author(s)
      Yurie Kura, Marco A De Velasco, Yasuyuki Kobayashi, Naomi Ando, Emiko Fukushima, Yutaka Yamamoto, Yuji Hatanaka, Nobutaka Shimizu, Kazuhiro Yoshimura, Masahiro Nozawa, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington DC
    • Year and Date
      2013-04-08
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Preclinical responses of the MEK inhibitor AZD6244 in a genetically modified mouse model of prostate cancer2013

    • Author(s)
      Hirotsugu Uemura, Marco A De Velasco, et al
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington DC
    • Year and Date
      2013-04-07
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] A ole for lumican as a biomarker of disease progression in human prostate adenocarcinoma2013

    • Author(s)
      Marco A De Velasco, Hirotsugu Uemura, et al
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington DC
    • Year and Date
      2013-04-07
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Autophagy is required for prostate cancer progression2013

    • Author(s)
      Marco A De Velasco, Yurie Kura, Naomi Ando, Emiko Fukushima, Yuji Hatanaka, Yutaka Yamamoto, Nobutaka Shimizu, Kazuhiro Yoshimura, Masahiro Nozawa, Kazuhiro Yoshikawa, Kazuto Nishio, Hirotsugu Uemura
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington DC
    • Year and Date
      2013-04-07
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Diet-induced leptin contributes to prostate cancer progression2012

    • Author(s)
      Marco A De Velasco, Hirotsugu Uemura, et al.
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-21
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] 転移性腎がんに対するMHC クラスI ペプチドワクチン療法の役割2012

    • Author(s)
      植村天受、吉村一宏、南 高文、デベラスコ マルコ
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] ヒト前立腺がんにおけるルミカンの発現について2012

    • Author(s)
      吉村一宏、デベラスコ マルコ、植村天受、他
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-20
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] 前立腺特異的PTENノックアウトマウスにおけるSTAT3 の転写活性に関する検討2012

    • Author(s)
      小林泰之、デベラスコ マルコ、植村天受、他
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-21
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] 前立腺癌マウスモデルに対する分子標的治療薬の抗腫瘍効果の検討2012

    • Author(s)
      山本豊、デベラスコ マルコ、倉由吏恵、畑中祐二、吉村一宏、清水信貴、野澤昌弘、吉川和宏、西尾和人、植村天受
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-21
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] The Clinical role of peptide vaccines for castration-resistant prostate cancer2012

    • Author(s)
      Takafumi Minami, Takahiro Kimura, Masahiro Nozawa, Kazuhiro Yoshimura, Toru Nakagawa, Akira Yamada, Kyogo Ito, Hiroyuki Fujimoto, Shi Egawa, Hirotsugu Uemura
    • Organizer
      The 10th Annual Meeting of Japanese Society of Medical Oncology
    • Place of Presentation
      Osaka
    • Year and Date
      2012-07-18
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] HLA-A24 陽性腎細胞癌患者におけるcancer-reactive CTLs を誘導し得るEpoR 抗原由来ペプチドの同定2012

    • Author(s)
      南 高文、南 知子、大関孝之、デベラスコマルコ、清水信貴、山本 豊、辻 秀憲、野澤昌弘、吉村一宏、植村天受
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-19
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] Role of Stat3 transcriptional activation in a preclinical mouse model of prostate cancer and potential as a therapeutic target2012

    • Author(s)
      De Velasco MA, Uemura H, et al.
    • Organizer
      Cancer Res
    • Year and Date
      2012-04-15
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] ヒト前立腺癌の進展におけるHOXA10 の発現異常について2012

    • Author(s)
      畑中祐二、デベラスコ マルコ、植村天受、他
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Year and Date
      2012-09-21
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Enhanced anti-tumor effects using a combinatorial targeted treatment strategy in a preclinical model of prostate cancer2012

    • Author(s)
      De Velasco MA, Uemura H, et al
    • Organizer
      Cancer Res
    • Year and Date
      2012-04-15
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] A phase I trial of VEGFR1 peptide vaccines for patients with metastatic renal cell carcinoma2011

    • Author(s)
      植村天受
    • Organizer
      Annual Meeting of American Urological Association
    • Place of Presentation
      ワシントン
    • Year and Date
      2011-05-17
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] Anti-tumor effects of everolimus and chlormadinone acetate against prostate cancer in a pre-clinical mouse model2010

    • Author(s)
      De Velasaco M., Uemura H., et al.
    • Organizer
      69th Annual Meeting of the Japanese Cancer Association
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Pre-clinical chemopreventive efficacy of chlormadinone acetate against prostate cancer2010

    • Author(s)
      Koike H., De Velasco M., Uemura H., et al
    • Organizer
      69th Annual Meeting of the Japanese Cancer Association
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-23
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] The prostate-specific PTEN conditional knockout mouse as a model for human prostate cancer2010

    • Author(s)
      De Velasaco M., Uemura H., et al.
    • Organizer
      69th Annual Meeting of the Japanese Cancer Association
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Uemura H. Insights into treatment efficacy in Japanese metastatic renal cell carcinoma patients2009

    • Author(s)
      Uemura H.
    • Organizer
      The 24^<th> Annual Meeting of European Association of Urology
    • Place of Presentation
      Stockholm Sweden
    • Year and Date
      2009-03-17
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] A phase-II study of CA9 peptide vaccines in combination with mterferon-alpha in advaced renal cell carcinoma. American Sociaty for Clinical Oncology2009

    • Author(s)
      Uemura H.
    • Organizer
      Genitourinary Cancer Symposium
    • Place of Presentation
      Orland USA
    • Year and Date
      2009-02-27
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] A phase II study of the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (mRCC)2008

    • Author(s)
      H. Uemura
    • Organizer
      24^<th> URS
    • Place of Presentation
      オランダ、アムステルダム
    • Year and Date
      2008-09-19
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] 転移性腎細胞癌に対する新規分子標的薬による治療経験2008

    • Author(s)
      植村天受
    • Organizer
      第46回日本癌治療学会総会
    • Place of Presentation
      名古屋市
    • Year and Date
      2008-10-31
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] Phase I/II study of individualized peptide vaccines for HLA-A2/A24 positive patients with hormone-refractory prostate cancer2008

    • Author(s)
      Uemura H.
    • Organizer
      The 44^<th> Annual Meeting of American Society for Clinical Oncology
    • Place of Presentation
      Chicago USA
    • Year and Date
      2008-05-31
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] A phase II study of the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (mRCC)2008

    • Author(s)
      Uemura H.
    • Organizer
      The 24^<th> Annual Meeting of Urological Research Society
    • Place of Presentation
      Amsterdam The Netherlands
    • Year and Date
      2008-09-19
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] 難治性腎細胞癌に対するペプチドワクチン療法2008

    • Author(s)
      植村天受
    • Organizer
      第21回日本バイオセラピィ学術集会総会
    • Place of Presentation
      東京
    • Year and Date
      2008-11-18
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] 難治性腎細胞癌に対するペプチドワクチン療法2008

    • Author(s)
      植村天受
    • Organizer
      第21回日本バイオセラピィ学会学術集会総会
    • Place of Presentation
      東京
    • Year and Date
      2008-11-18
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] Phase-I/II trial of CA9 peptide vaccination in combination with mterferon-alpha in HLA-A24 positive patients with cytokme refractory renal cell carcinoma2007

    • Author(s)
      Uemura H.
    • Organizer
      Annual Meeting of American Urological Association
    • Place of Presentation
      Anaheim USA
    • Year and Date
      2007-05-20
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] 難治性腎細胞癌に対する分子標的治療薬の使用経験2007

    • Author(s)
      植村天受
    • Organizer
      第45回日本癌治療学会総会
    • Place of Presentation
      京都市
    • Year and Date
      2007-10-24
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] サイトカイン療法抵抗性腎癌に対する新しい治療戦略2007

    • Author(s)
      植村天受
    • Organizer
      第37回日本腎臓学会西部学術大会
    • Place of Presentation
      福井市
    • Year and Date
      2007-10-20
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] Phase I/II study of CA9 peptide vaccination with interferon-alpha in cytokine refractory renal cancer patients2007

    • Author(s)
      Uemura H
    • Organizer
      第66回日本癌学会
    • Place of Presentation
      横浜市
    • Year and Date
      2007-10-04
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] A Phase I trial of vaccination of personalized peptides for HLA-A2/A24positive patients with hormone-refractory prostate cancer2007

    • Author(s)
      Uemura H
    • Organizer
      アメリカ泌尿器科学会
    • Place of Presentation
      アナハイム、USA
    • Year and Date
      2007-05-20
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] A phase I trial of vaccination of personalized peptides for HLA-A2/A24 positive patients with hormone-refractory prostate cancer2007

    • Author(s)
      Uemura H.
    • Organizer
      Annual Meeting of American Urological Association
    • Place of Presentation
      Anaheim USA
    • Year and Date
      2007-05-20
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] CA9 peptide vaccination in combination with mterferon-alpha in HLA-A24 positive patients with cytokme refractory renal cell carcinoma2007

    • Author(s)
      Uemura H.
    • Organizer
      The 24^<th> Annual Meeting of Urological Research Society
    • Place of Presentation
      CA USA
    • Year and Date
      2007-10-26
    • Data Source
      KAKENHI-PROJECT-19390419
  • [Presentation] Development of a lethal genetically engineered mouse model of prostate cancer for surivival studies and end-stage cancer

    • Author(s)
      植村天受、倉由吏恵、畑中祐二、山本 豊、清水信貴、吉村一宏、野澤昌弘、吉川和宏、西尾和人、デベラスコ マルコ
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜市(パシフィコ横浜)
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] The role of autophagy in prostate tumorigenesis and its therapeutic implications

    • Author(s)
      M.A. De Velasco, Y. Kura, N. Ando, E. Fukushima, Y. Hatanaka, Y. Yamamoto, N. Shimizu, K. Yoshimura, M. Nozawa, K. Yoshikawa, K. Nishio and H. Uemura
    • Organizer
      AACR
    • Place of Presentation
      San Diego
    • Year and Date
      2014-04-05 – 2014-04-09
    • Data Source
      KAKENHI-PROJECT-26670707
  • [Presentation] HLA-A24陽性腎細胞癌患者におけるcancer-rective CTLsを誘導し得るEpoR抗原由来ペプチドの同定

    • Author(s)
      南 高文、植村天受ほか
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] Autophagy is required for prostate cancer progression

    • Author(s)
      De Velasco M., Y. Kura, Uemura H. et.al.
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington, DC, USA
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Functional evaluation of synchronous inactivation of PTEN and P53 in a murine model of prostate cancer.

    • Author(s)
      H. Uemura, Y. Kura, N. Ando, E. Fukushima, Y. Hatanaka, Y. Yamamoto, N. Shimizu, K. Yoshimura, M. Nozawa, K. Yoshikawa, K. Nishio and M.A. De Velasco
    • Organizer
      AACR
    • Place of Presentation
      San Diego
    • Year and Date
      2014-04-05 – 2014-04-09
    • Data Source
      KAKENHI-PROJECT-26462433
  • [Presentation] Preclinical responses of the MEK inhibitor AZD6244 in an genetically modified mouse model of prostate cancer

    • Author(s)
      Uemura H., Kura Y., De Velasco M. et.al.
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington, DC, USA
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] A role for iumican as a biomarker of disease progression in human prostate adenocarcinoma

    • Author(s)
      De Verasco M., Hatanaka Y., Uemura H. et.al.
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington, DC, USA
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] Autophagy in prostate tumorigenes and its clinical implications

    • Author(s)
      デベラスコ マルコ、倉由吏恵、畑中祐二、山本 豊、清水信貴、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜市(パシフィコ横浜)
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-26670707
  • [Presentation] Interleukin-6(IL-6) as a therapeutic target in prostate cancer

    • Author(s)
      Kura Y., De Velasco M., Uemura H. et.al.
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington, DC, USA
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] 転移性腎癌に対するMHCクラスIペプチドワクチン療法の役割

    • Author(s)
      植村天受、吉村一宏ほか
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Data Source
      KAKENHI-PROJECT-22390305
  • [Presentation] Leptin contributes to prostate cancer

    • Author(s)
      De Velasco M., Yamamot Y., Uemura H. et.al.
    • Organizer
      AACR Annual Meeting 2013
    • Place of Presentation
      Washington, DC, USA
    • Data Source
      KAKENHI-PROJECT-22591781
  • [Presentation] 前立腺癌におけるオートファジーの生物学的意義

    • Author(s)
      デベラスコ マルコ、倉由吏恵、安藤直美、福島恵美子、畑中祐二、山本 豊、清水信貴、吉村一宏、野澤昌弘、吉川和宏、西尾和人、植村天受
    • Organizer
      第102回日本泌尿器科学会総会
    • Place of Presentation
      神戸市(神戸国際会議場・神戸国際展示場・神戸ポートピアホテル)
    • Year and Date
      2014-04-24 – 2014-04-27
    • Data Source
      KAKENHI-PROJECT-26670707
  • 1.  YOSHIKAWA Kazuhiro (60109759)
    # of Collaborated Projects: 11 results
    # of Collaborated Products: 3 results
  • 2.  DEVELASCO Marco (20449838)
    # of Collaborated Projects: 10 results
    # of Collaborated Products: 83 results
  • 3.  HIRAO Yoshihiko (00133207)
    # of Collaborated Projects: 10 results
    # of Collaborated Products: 3 results
  • 4.  MINAMI Takafumi (70340809)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 15 results
  • 5.  TANAKA Motoyoshi (30347562)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 10 results
  • 6.  CHO Masaki (90285362)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 0 results
  • 7.  HARADA Mamoru (50260716)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 6 results
  • 8.  YOSHIMURA Kazuhiro (20283757)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 14 results
  • 9.  NOZAWA Masahiro (00441080)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 10.  UEJIMA Shigeya (60213336)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 11.  SHIMADA Keiji (90336850)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 12.  OKAJIMA Eigoro (50075115)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 13.  FUJIMOTO Kiyohide (50264867)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 14.  KONISHI Noboru (20145832)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 15.  OZONO Seiichiro (00183228)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 16.  TSUNODA Takuya (30275359)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 17.  SAGA Shinsuke (40144141)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 18.  TANAKA Masahiro (00382292)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 19.  百瀬 均 (20210106)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  仲川 嘉紀 (60281276)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 21.  岡島 英二郎 (70326346)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 22.  坂本 信一 (70422235)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 23.  西尾 和人 (10208134)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 24.  金田 篤志 (10313024)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 25.  今村 有佑 (10568629)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 26.  坂井 和子 (20580559)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 27.  川上 英良 (30725338)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 28.  落谷 孝広 (60192530)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 29.  安西 尚彦 (70276054)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 30.  太田 明伸
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 31.  松原 昭郎
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 32.  原嶋 奈々江
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 33.  井手 久満
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to connect your ORCID iD to this researcher?
* This action can be performed only by the researcher themselves.

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi